BioCentury
ARTICLE | Financial News

Ophthalmology company Novaliq raises $53M

October 11, 2018 11:22 PM UTC

Ophthalmology company Novaliq GmbH (Heidelberg, Germany) raised $53 million on Oct. 11 from existing investor dievini Hopp BioTech holding GmbH & Co. KG (Walldorf, Germany). Novaliq has raised $115 million to date.

The company's lead assets are CyclASol and NOV03 (Mysol)...